WallStreetZenWallStreetZen

NYSE: CNMD
Conmed Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CNMD past earnings growth

How has CNMD's earnings growth performed historically?
Company
N/A
Industry
87.87%
Market
107.64%
CNMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CNMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

CNMD past revenue growth

How has CNMD's revenue growth performed historically?
Company
19.06%
Industry
9.39%
Market
17.61%
CNMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CNMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CNMD's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CNMD earnings and revenue history

Current Revenue
$1.2B
Current Earnings
$64.5M
Current Profit Margin
5.2%
CNMD's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CNMD Return on Equity

Current Company
8.2%
Current Industry
10.5%
Current Market
188%
CNMD's Return on Equity (8.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CNMD announces earnings.

CNMD Return on Assets

Current Company
2.8%
Current Industry
5.3%
CNMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CNMD Return on Capital Employed

Current Company
6.06%
Current Industry
8.3%
CNMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNMD vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CNMD$1.24B$136.80M$64.46M+7.68%+7.69%
NARI$493.63M$15.18M-$1.64M+135.40%N/A
TNDM$747.72M-$194.66M-$222.61M+32.39%N/A
RXST$89.08M-$41.04M-$48.61M+151.09%N/A
IART$1.54B$258.15M$67.74M+0.92%+3.09%
View Top Medical Device Stocks

CNMD earnings dates

Next earnings date
Apr 24, 2024

Conmed Earnings & Revenue FAQ

What were CNMD's earnings last quarter?

On Invalid Date, Conmed (NYSE: CNMD) reported Q4 2023 earnings per share (EPS) of $1.08, up 18.68% year over year. Total Conmed earnings for the quarter were $33.07 million. In the same quarter last year, Conmed's earnings per share (EPS) was $0.91.

If you're new to stock investing, here's how to buy Conmed stock.

What was CNMD's earnings growth in the past year?

As of Q2 2024, Conmed's earnings has grown year over year. Conmed's earnings in the past year totalled $64.46 million.

What is CNMD's earnings date?

Conmed's earnings date is Invalid Date. Add CNMD to your watchlist to be reminded of CNMD's next earnings announcement.

What was CNMD's revenue last quarter?

On Invalid Date, Conmed (NYSE: CNMD) reported Q4 2023 revenue of $327.05 million up 30.37% year over year. In the same quarter last year, Conmed's revenue was $250.87 million.

What was CNMD's revenue growth in the past year?

As of Q2 2024, Conmed's revenue has grown 19.06% year over year. This is 9.67 percentage points higher than the US Medical Devices industry revenue growth rate of 9.39%. Conmed's revenue in the past year totalled $1.24 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.